Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|April 27, 2017
MYC and AMPK-Save Energy or Die!Heidi M Haikala, Johanna M Anttila, Juha KlefströmMolecular Oncology|September 26, 2021
Sortilin-related receptor is a druggable therapeutic target in breast cancerHussein Al-Akhrass, Mika Pietilä, Johanna Lilja, et al.Molecular Oncology|October 24, 2023
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axisDenis Belitškin, Pauliina Munne, Shishir M Pant, et al.Nature Communications|June 27, 2022
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancerJoyce V Lee, Filomena Housley, Christina Yau, et al.Nature Communications|February 22, 2019
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyHeidi M Haikala, Johanna M Anttila, Elsa Marques, et al.Nature Communications|February 8, 2019
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyHeidi M Haikala, Johanna M Anttila, Elsa Marques, et al.Cell Reports|July 3, 2026
Complex I drives glutamine-dependent TCA cycle to support viability of MYC<sup>high</sup> breast cancer cellsJohanna M Anttila, Mariel Savelius, Linda Id, et al.Pageof 1